These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 28069158)

  • 1. Systolic myocardial volume gain in dilated, hypertrophied and normal heart. CMR study.
    Mazurkiewicz Ł; Orłowska-Baranowska E; Petryka J; Śpiewak M; Gawor M; Miłosz-Wieczorek B; Werys K; Małek ŁA; Marczak M; Grzybowski J
    Clin Radiol; 2017 Apr; 72(4):286-292. PubMed ID: 28069158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of delayed enhancement magnetic resonance imaging to differentiate dilated phase of hypertrophic cardiomyopathy and dilated cardiomyopathy.
    Matoh F; Satoh H; Shiraki K; Saitoh T; Urushida T; Katoh H; Takehara Y; Sakahara H; Hayashi H
    J Card Fail; 2007 Jun; 13(5):372-9. PubMed ID: 17602984
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertrophic non-obstructive cardiomyopathy assessed by dipyridamole thallium single photon emission computed tomography: comparisons with hypertrophic cardiomyopathy with a dilated heart].
    Mori T; Suda K; Ohnishi M; Kanoh Y; Shiotani H; Yokota Y; Fujitani K; Fukuzaki H; Maeda K
    J Cardiol; 1987 Mar; 17(1):35-46. PubMed ID: 3501444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fat deposition in dilated cardiomyopathy assessed by CMR.
    Lu M; Zhao S; Jiang S; Yin G; Wang C; Zhang Y; Liu Q; Cheng H; Ma N; Zhao T; Chen X; Huang J; Zou Y; Song L; He Z; An J; Renate J; Xue H; Shah S
    JACC Cardiovasc Imaging; 2013 Aug; 6(8):889-98. PubMed ID: 23850250
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Ventricular volumes determined by single-photon emission computed tomography].
    Katohno E; Ono K; Owada K; Fujino A; Watanabe N; Sato M; Konno I; Yaoita H; Tsuda F; Kariyone S
    J Cardiol; 1987 Jun; 17(2):329-39. PubMed ID: 2834530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myocardial extracellular volume fraction measurements with MOLLI 5(3)3 by cardiovascular MRI for the discrimination of healthy volunteers from dilated and hypertrophic cardiomyopathy patients.
    Cui Y; Chen Y; Cao Y; Liu J; Song J; Zhang S; Kong X; Han P; Shi H
    Clin Radiol; 2019 Sep; 74(9):732.e9-732.e16. PubMed ID: 31122714
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of mitral annulus size and function by real-time 3-dimensional echocardiography in cardiomyopathy: comparison with magnetic resonance imaging.
    Anwar AM; Soliman OI; Nemes A; Germans T; Krenning BJ; Geleijnse ML; Van Rossum AC; ten Cate FJ
    J Am Soc Echocardiogr; 2007 Aug; 20(8):941-8. PubMed ID: 17555937
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Distribution of late gadolinium enhancement in end-stage hypertrophic cardiomyopathy and dilated cardiomyopathy: differential diagnosis and prediction of cardiac outcome.
    Machii M; Satoh H; Shiraki K; Saotome M; Urushida T; Katoh H; Takehara Y; Sakahara H; Ohtani H; Wakabayashi Y; Ukigai H; Tawarahara K; Hayashi H
    Magn Reson Imaging; 2014 Feb; 32(2):118-24. PubMed ID: 24315973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of left atrial function on pulmonary arterial pressure in acute myocardial infarction, hypertrophic and dilated cardiomyopathy.
    Kim M; Chung H; Kim IS; Park CH; Rim SJ; Choi EY
    BMC Cardiovasc Disord; 2022 Nov; 22(1):507. PubMed ID: 36435744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of Myocardial Microstructural Dynamics by In Vivo Diffusion Tensor Cardiac Magnetic Resonance.
    Nielles-Vallespin S; Khalique Z; Ferreira PF; de Silva R; Scott AD; Kilner P; McGill LA; Giannakidis A; Gatehouse PD; Ennis D; Aliotta E; Al-Khalil M; Kellman P; Mazilu D; Balaban RS; Firmin DN; Arai AE; Pennell DJ
    J Am Coll Cardiol; 2017 Feb; 69(6):661-676. PubMed ID: 28183509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Unclassified cardiomyopathies: subspecies and their transformation].
    Ikeda Y; Kawai S; Okada R; Yamaguchi H
    J Cardiol; 1998 Feb; 31(2):91-7. PubMed ID: 9513036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is cardiac and hepatic iron status assessed by MRI T2* associated with left ventricular function in patients with idiopathic cardiomyopathy?
    Kanzaki Y; Yuki M; Yamamura KI; Narumi Y; Ishizaka N
    Heart Vessels; 2016 Dec; 31(12):1950-1959. PubMed ID: 26897743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac magnetic resonance radiomics for disease classification.
    Zhang X; Cui C; Zhao S; Xie L; Tian Y
    Eur Radiol; 2023 Apr; 33(4):2312-2323. PubMed ID: 36378251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitral annular plane systolic excursion is an easy tool for fibrosis detection by late gadolinium enhancement cardiovascular magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
    Doesch C; Sperb A; Sudarski S; Lossnitzer D; Rudic B; Tülümen E; Heggemann F; Schimpf R; Schoenberg SO; Borggrefe M; Papavassiliu T
    Arch Cardiovasc Dis; 2015; 108(6-7):356-66. PubMed ID: 25863428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.
    Urbano-Moral JA; Rowin EJ; Maron MS; Crean A; Pandian NG
    Circ Cardiovasc Imaging; 2014 Jan; 7(1):11-9. PubMed ID: 24275954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.
    Hinojar R; Varma N; Child N; Goodman B; Jabbour A; Yu CY; Gebker R; Doltra A; Kelle S; Khan S; Rogers T; Arroyo Ucar E; Cummins C; Carr-White G; Nagel E; Puntmann VO
    Circ Cardiovasc Imaging; 2015 Dec; 8(12):. PubMed ID: 26659373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Right ventricular myocardial involvement in either physiological or pathological left ventricular hypertrophy: an ultrasound speckle-tracking two-dimensional strain analysis.
    D'Andrea A; Caso P; Bossone E; Scarafile R; Riegler L; Di Salvo G; Gravino R; Cocchia R; Castaldo F; Salerno G; Golia E; Limongelli G; De Corato G; Cuomo S; Pacileo G; Russo MG; Calabrò R
    Eur J Echocardiogr; 2010 Jul; 11(6):492-500. PubMed ID: 20551250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial Fibrosis in Hypertrophic Cardiomyopathy: Volumetric Assessment of Late Enhancement Provided by Cardiac Computed Tomography.
    Langer C; Schaefer P; Lutz M; Eden M; Hohnhorst M; Harders H; Faber L; Jansen O; Both M; Frey N
    J Comput Assist Tomogr; 2015; 39(5):797-803. PubMed ID: 26125299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progression from hypertrophic obstructive cardiomyopathy to typical dilated cardiomyopathy-like features in the end stage.
    Fujiwara H; Onodera T; Tanaka M; Shirane H; Kato H; Yoshikawa J; Osakada G; Sasayama S; Kawai C
    Jpn Circ J; 1984 Nov; 48(11):1210-4. PubMed ID: 6542151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of myocardial fibrosis and ventricular dyssynchrony on response to therapy in new-presentation idiopathic dilated cardiomyopathy: insights from cardiovascular magnetic resonance and echocardiography.
    Leong DP; Chakrabarty A; Shipp N; Molaee P; Madsen PL; Joerg L; Sullivan T; Worthley SG; De Pasquale CG; Sanders P; Selvanayagam JB
    Eur Heart J; 2012 Mar; 33(5):640-8. PubMed ID: 22048681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.